Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA binding motif protein 22 pseudogene 1 (RBM22P1)
- Target
- RBM22P1
- Molecular classification
- Pseudogene, Long non-coding RNA (lncRNA)
01
Overview
RNA binding motif protein 22 pseudogene 1 (RBM22P1) is a human pseudogene, defined as a non-functional genomic sequence that resembles the protein-coding gene RNA binding motif protein 22 (RBM22) but does not produce a functional protein[1][9]. Pseudogenes like RBM22P1 generally arise from gene duplication or retrotransposition events, and while some pseudogenes have regulatory or competing endogenous RNA (ceRNA) roles, there is currently no evidence that RBM22P1 has any demonstrated regulatory or pathological function[1][9]. As a non-coding, non-functional gene locus, RBM22P1 is not druggable and has no established role in human disease or pharmacology.
02
Mechanism of action
None known (pseudogenes are not targeted by drugs; no evidence RBM22P1 produces functional RNA or protein.)
03
Biological functions
No direct biological function; noncoding pseudogenes can sometimes act as regulatory long non-coding RNAs, but no documented function specific to RBM22P1
04
Disease associations
No known roles in disease; no documented relevance to cancer, inflammation, or other disease categories as of current knowledge
Beyond the preview
Go deeper on RNA binding motif protein 22 pseudogene 1 (RBM22P1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA binding motif protein 22 pseudogene 1 (RBM22P1).